Our Company
Humanity Can’t Wait Decades, Which is Why We Focus on Days
Led by the best and brightest in chemistry, informatics, AI and machine learning, our drug discovery platform empowers our drug discoverers and developers to create a growing pipeline of novel medicines for untreated or poorly treated diseases.
// ELEVATING HUMAN HEALTH
// WHO WE ARE
Meet the team
Our team combines expertise across AI/ML, medicinal chemistry, biology, and drug development. This fusion propels our mission to transform drug discovery through AI innovation.
-
Daniel Haders II, Ph.D
Founder, CEO
-
Sean M. Russell
Founder, COO
-
Patrick ONeill
Investor Relations
-
Tyler Umansky
Manager, Machine Learning
-
Navya Ramesh
Machine Learning Engineer
-
Virgil Woods
Fellow
-
Lani Nguyen
Design
-
Davey Smith, MD, MAS, FACP, FIDSA
Lead Clinical Advisor
-
Dr. Launa Aspeslet
Senior Scientific & Clinical Advisor
-
Sumit Chanda, Ph.D
Preclinical Development Partner & Advisor
-
Kris White, PhD
Preclinical Development Partner & Advisor
-
Arnab Chatterjee, Ph.D
Preclinical Development Partner & Advisor
-
Dr. David Garvey
Preclinical Advisor
-
Adolfo Garcia-Sastre, Ph.D
Preclinical Development Partner & Advisor
-
Tushar Menon, Ph.D
Scientific Advisor
-
William Brubaker, Ph.D
Preclinical Development Advisor
-
Rubén Darío Flores Saaib, Ph.D
Licensing Advisor
-
Bill Malloy
Board Member
-
Marlon Evans
Board Member
-
Kip Quackenbush
Board Member
// Invested in our Success
We’re backed by leading, multi-stage investors with significant expertise and sophistication in the Bio-IT/pharma space.
Our Values.
Forever changing the pharmaceutical industry.
-
Respect for patients first and foremost.
-
Tech that reliably discovers drug candidates in days rather than decades.
-
We give hope back to patients who have lost it along the way.
-
We work with the best to do our best, regardless of origin.
-
We are not afraid to challenge norms and tackle the big problems head on.